Hahn said the changes the agency will keep include a greater focus on decentralized clinical trials, ramping up laboratory-developed tests and increasing the use of telemedicine technology.
The FDA said it also is pivoting toward the use of real-world evidence to monitor medical products amid the pandemic.
More articles on pharmacy:
American Pharmacists Association swears in new CEO
5 recent CMS pharmacy policy changes
Eli Lilly testing COVID-19 drug derived from survivor blood
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
